Shattuck Labs(STTK)
AUSTIN, TX
BiotechnologyFocus: Immunotherapy platform
Shattuck Labs is a life sciences company focused on Immunotherapy platform.
Oncology
Funding Stage
PUBLIC
Open Jobs
1
Pipeline & Clinical Trials
SL-172154
Ovarian CancerClinical Trials (1)
NCT04406623Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer
Phase 1Drug: SL-172154
Cutaneous Squamous Cell CarcinomaClinical Trials (1)
NCT04502888Ph1 Study of SL-172154 Administered Intratumorally in Subjects With Squamous Cell Carcinoma of the Head and Neck or Skin
Phase 1SL-172154
Acute Myeloid LeukemiaClinical Trials (1)
NCT05275439Phase 1 Study of Shattuck Labs (SL)-172154 in Subjects With MDS or AML
Phase 1Phase 1
Clinical Trials (1)
NCT03894618SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
Phase 1Pegylated Liposomal Doxorubicin + SL-172154
Platinum-resistant Ovarian CancerClinical Trials (1)
NCT05483933Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
Phase 1SL-325
Healthy VolunteersClinical Trials (1)
NCT07158437Phase 1 Study of SL-325 in Healthy Volunteers
Phase 1Open Jobs (1)
Interview Prep Quick Facts
Portfolio: 6 clinical trials
SEC Filings: 2 available
Open Roles: 1 active job
Financials (FY2025)
Revenue
$6M245%
R&D Spend
$67M(1175%)10%
Net Income
-$75MCash
$57MHiring Trend
Stable
1
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles